Unbound MEDLINE

Novel lipoidal amine-based nanocarrier formulations for siRNA delivery.

Abstract

BACKGROUND
Lack of safe and efficient delivery of siRNA remains the greatest hurdle for the therapeutic application of siRNA. This article reports synthesis and evaluation of novel lipoidal amine-based nanocarrier (LANC) formulations for siRNA delivery.
METHOD
Physicochemical properties were analyzed for LANC formulations. siRNA delivery efficiency of LANC-siRNA complexes was determined using a luciferase reporter gene assay. Cytotoxicity of the LANC-siRNA complexes was measured by the MTS assay. Finally, cellular uptake and cytoplasmic release of siRNA were analyzed using flow cytometry.
CONCLUSION
The LANC formulation facilitated siRNA uptake and release into the cytoplasm, mediating significant luciferase knockdown (70% inhibition).

Links

  • Aggregator Full Text
  • Authors

    Zhou C, Yue Z, Lee LJ, Lee RJ

    Institution

    Division of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.

    Source

    Therapeutic delivery 3:6 2012 Jun pg 715-23

    MeSH

    Biological Transport
    Cell Line, Tumor
    Cell Survival
    Cytoplasm
    Diamines
    Flow Cytometry
    Gene Therapy
    Genes, Reporter
    Humans
    Lipids
    Luciferases
    Nanoparticles
    Particle Size
    RNA Interference
    RNA, Small Interfering
    Transfection

    Pub Type(s)

    Journal Article
    Research Support, N.I.H., Extramural
    Research Support, Non-U.S. Gov't
    Research Support, U.S. Gov't, Non-P.H.S.

    Language

    eng

    PubMed ID

    22838067